Inline with our data, Kiniwa et al showed FoxP3 gene expression in both CD4 and CD8 T cells derived from prostate tumor infiltrating lymphocytes (TILs), and also their expression was higher compared to effector T cells [13]. The gene discussed is CD8A; the disease is prostate neoplasm.